An adenoviral vector based vaccine for Rhodococcus equi

0Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

© 2016 Giles et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Rhodococcus equi is a respiratory pathogen which primarily infects foals and is endemic on farms around the world with 50% mortality and 80% morbidity in affected foals. Unless detected early and treated appropriately the disease can be fatal. Currently, there is no vaccine available to prevent this disease. For decades researchers have endeavoured to develop an effective vaccine to no avail. In this study a novel human adenoviral vector vaccine for R. equi was developed and tested in the mouse model. This vaccine generated a strong antibody and cytokine response and clearance of R. equi was demonstrated following challenge. These results show that this vaccine could potentially be developed further for use as a vaccine to prevent R. equi disease in foals.

Cite

CITATION STYLE

APA

Giles, C., Ndi, O., Barton, M. D., & Vanniasinkam, T. (2016). An adenoviral vector based vaccine for Rhodococcus equi. PLoS ONE, 11(3). https://doi.org/10.1371/journal.pone.0152149

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free